Department of Genetics and Waksman Institute, Rutgers University, Piscataway, NJ 08854, USA.
J Mol Biol. 2011 Oct 7;412(5):772-81. doi: 10.1016/j.jmb.2011.06.015. Epub 2011 Jun 16.
It has been widely assumed that all transcription in cells occur using NTPs only (i.e., de novo). However, it has been known for several decades that both prokaryotic and eukaryotic RNA polymerases can utilize small (2 to ∼5 nt) RNAs to prime transcription initiation in vitro, raising the possibility that small RNAs might also prime transcription initiation in vivo. A new study by Goldman et al. has now provided the first evidence that priming with so-called "nanoRNAs" (i.e., 2 to ∼5 nt RNAs) can, in fact, occur in vivo. Furthermore, this study provides evidence that altering the extent of nanoRNA-mediated priming of transcription initiation can profoundly influence global gene expression. In this perspective, we summarize the findings of Goldman et al. and discuss the prospect that nanoRNA-mediated priming of transcription initiation represents an underappreciated aspect of gene expression in vivo.
人们普遍认为细胞中的所有转录都只使用 NTPs(即从头合成)进行。然而,几十年来人们已经知道原核和真核 RNA 聚合酶都可以利用小的(2 到 ∼5 nt)RNA 在体外启动转录起始,这就提出了小 RNA 也可能在体内启动转录起始的可能性。Goldman 等人的一项新研究现在提供了第一个证据,表明所谓的“nanorNAs”(即 2 到 ∼5 nt 的 RNA)的引发实际上可以在体内发生。此外,这项研究还提供了证据表明,改变 nanoRNA 介导的转录起始引发的程度可以深刻影响全局基因表达。在这个观点中,我们总结了 Goldman 等人的发现,并讨论了 nanoRNA 介导的转录起始引发代表了体内基因表达中一个被低估的方面的前景。